BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2926794)

  • 41. Fatty acids and neutral sugars present in lipopolysaccharides isolated from Fusobacterium species.
    Hofstad T; Skaug N
    Acta Pathol Microbiol Scand B; 1980 Apr; 88(2):115-20. PubMed ID: 7376878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clindamycin-resistant Fusobacterium varium bacteremia and decubitus ulcer infection.
    Legaria MC; Lumelsky G; Rodriguez V; Rosetti S
    J Clin Microbiol; 2005 Aug; 43(8):4293-5. PubMed ID: 16082005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical spectrum of bacteraemic Fusobacterium infections: from septic shock to nosocomial bacteraemia.
    Nohrström E; Mattila T; Pettilä V; Kuusela P; Carlson P; Kentala E; Mattila PS
    Scand J Infect Dis; 2011 Jul; 43(6-7):463-70. PubMed ID: 21391770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A longitudinal study of the cultivable subgingival anaerobic bacteria isolated from sheep during the development of broken mouth periodontitis.
    McCourtie J; Poxton IR; Brown R; Whittaker CR; Spence JA; Aitchison GU
    J Med Microbiol; 1990 Apr; 31(4):275-83. PubMed ID: 2182879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increasing Fusobacterium infections with Fusobacterium varium, an emerging pathogen.
    Lee SJ; Baek YJ; Kim JN; Lee KH; Lee EH; Yeom JS; Choi JY; Ku NS; Ahn JY; Kim JH; Jeong SJ
    PLoS One; 2022; 17(4):e0266610. PubMed ID: 35421136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conversion of DL-threonine, D-threonine and 2-oxobutyrate into propionate and 2-hydroxybutyrate by Fusobacterium species.
    Carlier JP; Henry C; Lorin V; Rouffignat K
    Lett Appl Microbiol; 1997 Nov; 25(5):371-4. PubMed ID: 9418075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fusobacterium equinum sp. nov., from the oral cavity of horses.
    Dorsch M; Lovet DN; Bailey GD
    Int J Syst Evol Microbiol; 2001 Nov; 51(Pt 6):1959-63. PubMed ID: 11760934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fusobacterium necrophorum- detection and identification on a selective agar.
    Bank S; Nielsen HM; Mathiasen BH; Leth DC; Kristensen LH; Prag J
    APMIS; 2010 Dec; 118(12):994-9. PubMed ID: 21091782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The isolation of fusobacteria from tropical ulcers.
    Adriaans B; Drasar BS
    Epidemiol Infect; 1987 Oct; 99(2):361-72. PubMed ID: 3678397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationships among the oral fusobacteria assessed by DNA-DNA hybridization.
    Potts TV; Holdeman LV; Slots J
    J Dent Res; 1983 Jun; 62(6):702-5. PubMed ID: 6574153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gradenigo's syndrome: is fusobacterium different? Two cases and review of the literature.
    Heshin-Bekenstein M; Megged O; Peleg U; Shahroor-Karni S; Bass R; Benifla M; Bar-Meir M
    Int J Pediatr Otorhinolaryngol; 2014 Jan; 78(1):166-9. PubMed ID: 24315216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fusobacterium equinum possesses a leukotoxin gene and exhibits leukotoxin activity.
    Tadepalli S; Stewart GC; Nagaraja TG; Jang SS; Narayanan SK
    Vet Microbiol; 2008 Feb; 127(1-2):89-96. PubMed ID: 17913399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postpartum Fusobacterium gonidiaformans bacteremia.
    Vidaurrazaga MM; McKinley GF; Camins BC
    Anaerobe; 2020 Apr; 62():102168. PubMed ID: 32045837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sugar metabolism by fusobacteria: regulation of transport, phosphorylation, and polymer formation by Fusobacterium mortiferum ATCC 25557.
    Robrish SA; Oliver C; Thompson J
    Infect Immun; 1991 Dec; 59(12):4547-54. PubMed ID: 1937813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fusobacterium necrophorum bacteremic tonsillitis: 2 Cases and a review of the literature.
    Centor RM; Geiger P; Waites KB
    Anaerobe; 2010 Dec; 16(6):626-8. PubMed ID: 20813196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Differences in Patients Infected with
    Kim M; Yun SY; Lee Y; Lee H; Yong D; Lee K
    Ann Lab Med; 2022 Mar; 42(2):188-195. PubMed ID: 34635612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pathogenic properties of Fusobacterium and Bacteroides species from wallabies and other sources.
    Smith GR; Oliphant JC; Parsons R
    J Hyg (Lond); 1984 Apr; 92(2):165-75. PubMed ID: 6707469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proposal of three subspecies of Fusobacterium nucleatum Knorr 1922: Fusobacterium nucleatum subsp. nucleatum subsp. nov., comb. nov.; Fusobacterium nucleatum subsp. polymorphum subsp. nov., nom. rev., comb. nov.; and Fusobacterium nucleatum subsp. vincentii subsp. nov., nom. rev., comb. nov.
    Dzink JL; Sheenan MT; Socransky SS
    Int J Syst Bacteriol; 1990 Jan; 40(1):74-8. PubMed ID: 2223601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Fusobacterium necrophorum: from tonsillitis to Lemierre's syndrome].
    Kristensen LH; Jensen A; Prag J
    Ugeskr Laeger; 2009 Mar; 171(12):987-90. PubMed ID: 19284917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytotoxicity of Fusobacterium ulcerans.
    Adriaans B; Garelick H
    J Med Microbiol; 1989 Jul; 29(3):177-80. PubMed ID: 2746628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.